Literature DB >> 14678267

Modulation of antigen presentation by autoreactive B cell clones specific for GAD65 from a type I diabetic patient.

J P Banga1, J K Moore, N Duhindan, A M Madec, P M van Endert, J Orgiazzi, J Endl.   

Abstract

We used a GAD65-specific human B-T cell line cognate system in vitro to investigate the modulation of GAD65 presentation by autoantibody, assessed in a proliferation assay. Generally, if the T cell determinant overlaps or resides within the antibody epitope, effects of presentation are blunted while if they are distant can lead to potent presentation. For three different autoreactive B-T cell line cognate pairs, the modulation of GAD65 presentation followed the mode of overlapping or distant epitopes with resultant potent or undetectable presentation. However, other cognate pairs elicited variability in this pattern of presentation. Notably, one B cell line, DPC, whose antibody epitope did not overlap with the T cell determinants, was consistently poor in presenting GAD65. Using the fluorescent dye Alexa Fluor 647 conjugated to GAD65 to study receptor-mediated antigen endocytosis showed that all the antigen-specific B cell clones were efficient in intracellular accumulation of the antigen. Additionally, multicolour immunofluorescence microscopy showed that the internalized GAD65/surface IgG complexes were rapidly targeted to a perinuclear compartment in all GAD-specific B cell clones. This analysis also demonstrated that HLA-DM expression was reduced strongly in DPC compared to the stimulatory B cell clones. Thus the capability of antigen-specific B cells to capture and present antigen to human T cell lines is dependent on the spatial relationship of B and T cell epitopes as well other factors which contribute to the efficiency of presentation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14678267      PMCID: PMC1808922          DOI: 10.1111/j.1365-2249.2004.02343.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  34 in total

Review 1.  HLA-DM, HLA-DO and tapasin: functional similarities and differences.

Authors:  Pascale Brocke; Natalio Garbi; Frank Momburg; Günter J Hämmerling
Journal:  Curr Opin Immunol       Date:  2002-02       Impact factor: 7.486

2.  Development of type 1 diabetes despite severe hereditary B-cell deficiency.

Authors:  S Martin; D Wolf-Eichbaum; G Duinkerken; W A Scherbaum; H Kolb; J G Noordzij; B O Roep
Journal:  N Engl J Med       Date:  2001-10-04       Impact factor: 91.245

3.  Comparative analysis of epitope recognition of glutamic acid decarboxylase (GAD) by autoantibodies from different autoimmune disorders.

Authors:  A C Powers; K Bavik; J Tremble; K Daw; W A Scherbaum; J P Banga
Journal:  Clin Exp Immunol       Date:  1999-12       Impact factor: 4.330

Review 4.  Role of B-cell and Fc receptors in the selection of T-cell epitopes.

Authors:  S Amigorena; C Bonnerot
Journal:  Curr Opin Immunol       Date:  1998-02       Impact factor: 7.486

5.  B cell specificity contributes to the outcome of diabetes in nonobese diabetic mice.

Authors:  C Hulbert; B Riseili; M Rojas; J W Thomas
Journal:  J Immunol       Date:  2001-11-15       Impact factor: 5.422

6.  GAD65-specific autoantibodies enhance the presentation of an immunodominant T-cell epitope from GAD65.

Authors:  H Reijonen; T L Daniels; A Lernmark; G T Nepom
Journal:  Diabetes       Date:  2000-10       Impact factor: 9.461

7.  Conformational epitopes on the diabetes autoantigen GAD65 identified by peptide phage display and molecular modeling.

Authors:  M A Myers; J M Davies; J C Tong; J Whisstock; M Scealy; I R Mackay; M J Rowley
Journal:  J Immunol       Date:  2000-10-01       Impact factor: 5.422

8.  B lymphocytes are crucial antigen-presenting cells in the pathogenic autoimmune response to GAD65 antigen in nonobese diabetic mice.

Authors:  M Falcone; J Lee; G Patstone; B Yeung; N Sarvetnick
Journal:  J Immunol       Date:  1998-08-01       Impact factor: 5.422

9.  B lymphocytes are critical antigen-presenting cells for the initiation of T cell-mediated autoimmune diabetes in nonobese diabetic mice.

Authors:  D V Serreze; S A Fleming; H D Chapman; S D Richard; E H Leiter; R M Tisch
Journal:  J Immunol       Date:  1998-10-15       Impact factor: 5.422

10.  Functional HLA-DM on the surface of B cells and immature dendritic cells.

Authors:  S O Arndt; A B Vogt; S Markovic-Plese; R Martin; G Moldenhauer; A Wölpl; Y Sun; D Schadendorf; G J Hämmerling; H Kropshofer
Journal:  EMBO J       Date:  2000-03-15       Impact factor: 11.598

View more
  15 in total

Review 1.  Protective role of anti-idiotypic antibodies in autoimmunity--lessons for type 1 diabetes.

Authors:  Christiane S Hampe
Journal:  Autoimmunity       Date:  2012-02-23       Impact factor: 2.815

2.  Glutamic acid decarboxylase 65 and islet cell antigen 512/IA-2 autoantibodies in relation to human leukocyte antigen class II DR and DQ alleles and haplotypes in type 1 diabetes mellitus.

Authors:  Mouna Stayoussef; Jihen Benmansour; Fayza A Al-Jenaidi; Hichem B Said; Chiheb B Rayana; Touhami Mahjoub; Wassim Y Almawi
Journal:  Clin Vaccine Immunol       Date:  2011-04-13

3.  Changes in GAD65Ab-specific antiidiotypic antibody levels correlate with changes in C-peptide levels and progression to islet cell autoimmunity.

Authors:  E Ortqvist; B Brooks-Worrell; K Lynch; J Radtke; L M Bekris; I Kockum; C-D Agardh; C M Cilio; A L Lethagen; B Persson; A Lernmark; J Reichow; S Oak; J P Palmer; C S Hampe
Journal:  J Clin Endocrinol Metab       Date:  2010-08-04       Impact factor: 5.958

4.  Dynamic changes of GAD65 autoantibody epitope specificities in individuals at risk of developing type 1 diabetes.

Authors:  M Schlosser; J P Banga; A M Madec; K A Binder; M Strebelow; I Rjasanowski; R Wassmuth; L K Gilliam; D Luo; C S Hampe
Journal:  Diabetologia       Date:  2005-04-16       Impact factor: 10.122

5.  Epitope analysis of insulin autoantibodies using recombinant Fab.

Authors:  C J Padoa; N J Crowther; J W Thomas; T R Hall; L M Bekris; C Torn; M Landin-Olsson; E Ortqvist; J P Palmer; A Lernmark; C S Hampe
Journal:  Clin Exp Immunol       Date:  2005-06       Impact factor: 4.330

6.  Multiplicity of the antibody response to GAD65 in Type I diabetes.

Authors:  L K Gilliam; K A Binder; J P Banga; A-M Madec; E Ortqvist; I Kockum; D Luo; C S Hampe
Journal:  Clin Exp Immunol       Date:  2004-11       Impact factor: 4.330

7.  Autoantibody epitopes to the smaller isoform of glutamate decarboxylase do not differ in Swedish and Japanese type 1 diabetes patients and may be associated with high-risk human leucocyte antigen class II alleles.

Authors:  T Maruyama; S Oak; T R Hall; J P Banga; E Ortqvist; R A Ettinger; J Endl; C S Hampe
Journal:  Clin Exp Immunol       Date:  2007-10-22       Impact factor: 4.330

8.  B cells in autoimmune diabetes.

Authors:  F Susan Wong; Li Wen
Journal:  Rev Diabet Stud       Date:  2005-11-10

9.  Modulation of diabetes in NOD mice by GAD65-specific monoclonal antibodies is epitope specific and accompanied by anti-idiotypic antibodies.

Authors:  Tyler R Hall; Marika Bogdani; Renee C Leboeuf; Elizabeth A Kirk; Marlena Maziarz; J Paul Banga; Shilpa Oak; Christina A Pennington; Christiane S Hampe
Journal:  Immunology       Date:  2007-11-14       Impact factor: 7.397

10.  The lack of anti-idiotypic antibodies, not the presence of the corresponding autoantibodies to glutamate decarboxylase, defines type 1 diabetes.

Authors:  Shilpa Oak; Lisa K Gilliam; Mona Landin-Olsson; Carina Törn; Ingrid Kockum; Christina R Pennington; Merrill J Rowley; Michael R Christie; J Paul Banga; Christiane S Hampe
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-26       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.